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cedure per se does not cause substantial inflammation or 
skin damage, which is also of interest when applied to non-
invasive sampling of biomarkers in clinical trials.
© 2018 S. Karger AG, Basel
Introduction
The skin permeation of drugs depends on the site of ap-
plication and is strongly correlated with the hair follicle 
density [1]. The hair follicle is a reservoir for penetrated 
substances [2], and thus procedures to enhance this pen-
etration pathway are valuable tools in dermatopharmaceu-
tic research. Differential stripping methods have been 
widely used for investigations into the penetration of topi-
cally applied substances [3, 4] and have even been pro-
posed as methods to enhance penetration, e.g., in transcu-
taneous vaccination. With regard to hair follicle penetra-
tion cyanoacrylate skin surface stripping (CSSS), a variation 
of stripping using cyanoacrylate-based resins, is of special 
interest. Because the liquid resin flows into hair follicle 
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Abstract
The success of topically applied treatments on skin relies on 
the efficacy of skin penetration. In order to increase particle 
or product penetration, mild skin barrier disruption methods 
can be used. We previously described cyanoacrylate skin sur-
face stripping as an efficient method to open hair follicles, 
enhance particle penetration, and activate Langerhans cells. 
We conducted ex vivo and in vivo measurements on human 
skin to characterize the biological effect and quantify barrier 
disruption-related inflammation on a molecular level. De-
spite the known immunostimulatory effects, this barrier dis-
ruption and hair follicle opening method was well accepted 
and did not result in lasting changes of skin physiological 
parameters, cytokine production, or clinical side effects. 
Only in ex vivo human skin did we find a discrete increase in 
IP-10, TGF-β, IL-8, and GM-CSF mRNA. The data underline the 
safety profile of this method and demonstrate that the pro-
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openings, it has been successfully applied for recovery of 
skin surface material and hair follicle material [5–7], as well 
as proposed as a penetration enhancement method [8–10]. 
For both types of application, it is important to understand 
the biological effects induced by the procedure not only in 
ex vivo experiments, but also in in vivo settings.
Quantification of protein extracted from tapes is fre-
quently used for the investigation of interleukins and cy-
tokines in healthy and diseased skin and scalp [6, 11–14]. 
Because CSSS removes not only skin surface material, but 
approximately 30% of the stratum corneum [10], bio-
markers extracted from such material may yield more rel-
evant information compared to conventional adhesive 
tape strips. Several clinical studies suggest good tolerabil-
ity and safety, but possible biological effects or the extent 
of the additional inflammatory stimulus caused by the 
procedure have not been investigated. Such information 
is especially important when CSSS is integrated into clin-
ical trial protocols. It is known that even conventional 
adhesive tape strips induce substantial changes in gene 
expression. E.g., on a molecular level repetitive tape strip-
ping induced gene expression of different cytokines and 
chemokines, including TNF-α, IL-1α, and IL-1β [15, 16]. 
Defensins were found to be increased after repetitive tape 
stripping in a murine model [17], and epidermal mRNA 
expression of TNF-α, HSP-70, IL-33, and IL-8/CXCL8 
were increased in human biopsy samples [18].
Such biological effects become even more important 
with regard to the recently proposed use of CSSS as a 
method for penetration enhancement and immune acti-
vation in transcutaneous immunization patches [9, 19]. 
CSSS is highly interesting for transcutaneous immuniza-
tion as it targets the hair follicles as vaccine reservoir and 
immune organ. Data obtained from an ex vivo human 
skin model showed that the opening of hair follicles for 
penetration, the mild barrier disruption, and the subse-
quent pre-activation of dendritic cells were key to success 
of this vaccine delivery approach [20] and, besides being 
non-invasive, contributed to the observed induction of 
CD8 immune responses [19].
As the relevance of biomarkers increases in skin pen-
etration research and also with regard to cell-targeting 
strategies, inflammatory effects caused by the procedure 
itself are important aspects of interest to investigate the 
benefit of CSSS. It is essential to evaluate the extent and 
the quality of procedure-related biological effects.
Herein, we show ex vivo and in vivo results on the ef-
fects of conventional adhesive tape stripping or CSSS on 
skin physiological parameters, cytokine and chemokine 




An explorative clinical non-drug study was performed on 12 
volunteers (5 male and 7 female, average age 32.2 years, phototypes 
between II and III according to the Fitzpatrick classification). Eth-
ic approval EA1/132/13 was obtained from the ethics committee, 
Charité – Universitätsmedizin Berlin. The clinical study was con-
ducted at the Clinical Research Center for Hair and Skin Science, 
Department of Dermatology, Charité – University Medicine Ber-
lin, according to the ethical rules stated in the Declaration of Hel-
sinki. The aim of the study was to assess changes in skin barrier 
function and integrity after CSSS compared to conventional adhe-
sive tape stripping. Each volunteer was treated with 1 CSSS on 1 
upper arm (below the deltoid region) and 1 adhesive tape on the 
other upper arm. Left or right sides were assigned to the proce-
dures by randomization. Both CSSS and tape stripping remained 
attached to the skin for 20 min. For a visual graphic of study orga-
nization, please refer to online supplementary Figure 1 (for all on-
line suppl. material, see www.karger.com/doi/10.1159/000484443). 
In vivo CSSS and Tape Stripping
Two investigational sites of 4 cm × 4 cm, one on the upper left 
arm and another on the upper right arm, were each marked with a 
permanent skin marker (skin marker H7003 Falc). Subjects had to 
acclimatize in the measurement rooms for at least 30 min with the 
upper arms uncovered. Measurement rooms were temperature and 
humidity controlled (21 ± 2 ° C and 50 ± 10% humidity). Areas were 
marked and dry-shaved before the acclimatization time. A dry razor 
was used to shave the investigational test areas (Disposable razor, 
Art. No. 183 H, Wilkinson Sword GmbH, Germany). For the single-
step CSSS procedure, 180 mg of cyanoacrylate glue (9 drops, UHU 
Sekunden Alleskleber geruchsfrei Easy, UHU GmbH, Buehl/Baden, 
Germany) was spread onto the skin surface with a glass slide. Adhe-
sive tape (6 × 5 cm, Art. No. 57176-00000, 66 m × 50 mm, tesa® 
Beiersdorf, Beiersdorf, Germany) was cut to fit the test area size, 
then applied to the skin and massaged with a roll rubber (4.5 cm 
diameter, Lux series, OBI, Germany) 5 times back and forth to im-
prove adhesion. For the single tape stripping, the procedure was 
identical, but no cyanoacrylate glue was applied. Both CSSS and tape 
stripping materials were removed after 20 min attached to the skin.
Measurement of Cytokines in Blood after CSSS
For an additional 5 subjects, blood samples were collected after 
1 single 16-cm2 CSSS. IL-12p70, IL-10, IL-6, TNF-α, IL-1β, and 
IL-8 were measured using the Human Inflammation Kit BD Cyto-
metric Bead Array (BD Biosciences, San Diego, CA, USA) accord-
ing to manufacturer instructions.
In vivo Skin Physiology Measurements and Skin Surface 
Protein Harvesting and Protein Extraction
Measurements were performed using a Multi Probe Adapter 
MPA (Courage-Khazaka, Cologne, Germany). For details of skin 
physiology measurements and an overview of the methods, please 
refer to the supplementary material (see online suppl. Fig. 1). Stra-
tum corneum material was collected at different time points to 
quantify cytokines using Sebutape (S100 Sebutape patches, Cu-
Derm Corporation, Dallas, TX, USA). Details on protein harvest-
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Determination of Total Protein and ELISA
After protein extraction, total protein of samples was determined 
using the Micro BCA protein assay kit (No. 23235, Thermo Fisher 
Scientific Inc., Waltham, MA, USA) using bovine serum albumin as 
a standard. ELISA assays from Sebutape-extracted protein material 
for IL-1α, IL-1β, IL-1RA (DY200, DY201, and DY280, respectively, 
all from R & D Systems Inc.), for IL-6 (CytoSetTM No. CHC1263, In-
vitrogen Corporation, Camarillo, CA, USA), and IL-8 (CytoSetTM 
No. CHC1303, Invitrogen Corporation, Camarillo, USA) were per-
formed according to instructions provided by the kits.
Acceptability and Evaluation of Pain
Acceptability and pain perceived during the procedures were 
assessed using questionnaires and a visual analogue scale for pain.
Ex vivo Experiments
Ex vivo Skin Samples
Fresh skin samples were obtained from 7 healthy volunteers 
undergoing plastic surgery of the breast (n = 1) or the abdomen 
(n = 6). All skin samples were taken after informed consent ap-
proval by the Institutional Ethics Committee of the Charité Uni-
versitätsmedizin Berlin, according to the ethical rules stated in the 
Declaration of Helsinki. All donors (n = 7) were female between 
32 and 63 years of age (average age 45.8) and had phototypes be-
tween I and III according to the Fitzpatrick classification. After 
skin preparation (please refer to suppl. material), treatments and 
measurements were conducted.
Ex vivo Skin Physiology Measurements, Treatments, and 
Measurements
Skin physiology measurements were performed using a Multi 
Probe Adapter MPA (Courage-Khazaka, Cologne, Germany). For 
details, see supplementary materials.
Physical Barrier Disruption. Three fields of 1 cm2 each were 
marked on the skin. The fields were 1 cm apart from each other. 
One of them was left without treatment, on another a single tape 
stripping was performed using adhesive tape (TESA Beiersdorf, 
catalog No. 57176-00000, 66 m × 50 mm). To ensure standardized 
adhesion a rubber roll was used to evenly press the tape onto the 
skin surface. The tape remained on the skin for 20 min. On a third 
field mini-zone CSSS was performed as previously described [6, 
20] adding 1 drop of cyanoacrylate (UHU Sekunden Alleskleber 
geruchsfrei EASY, catalog No. 46130, UHU GmbH & Co. KG, Ger-
many), corresponding to 20 mg, before pressing on the adhesive 
tape.
Sequence of Skin Measurements. Skin physiology measure-
ments were performed prior to skin barrier disruption and after an 
incubation period of 24 h in a wet chamber at 37 ° C. Skin physiol-
ogy parameters were measured as described in the supplementary 
material. Skin surface material was collected using Sebutape (Seb-
utape®, CuDerm Corp., USA) and stored in 15-mL tubes (Fal-
con®, Corning Science México S.A. de C.V., México) using a for-
ceps and frozen at –80 ° C.
Protein Extraction from Diagnostic Sebutape and CSSS
To quantify different cytokines and chemokines, protein mate-
rial was extracted from the diagnostic strips (Sebutape and mini-
zone CSSS). The mini-zone CSSS strips were diluted according to 
Pfannes et al. [6]. For a detailed description, please refer to the 
online supplementary material.
Statistical Analysis
For the statistical analysis, 1-tailed paired Wilcoxon tests were 
performed using GraphPad Prism 5.0 (GraphPad Software Inc., La 
Jolla, CA, USA). For skin physiology measurements different 
treatment methods were compared, and within the treatments 
groups changes over time were evaluated. For IL-1α analysis dif-
ferent treatment methods were compared. 
RNA Extraction and qRT-PCR
For details on skin samples and skin preparation, please refer 
to the supplementary material. An RNeasy Mini Kit was used (Qia-
gen GmbH, Germany) for cell suspensions of up to 7 × 106 cells. 
The extracted RNA amount was quantified using a Nanodrop 
(Thermo Scientific, Wilmington, NC, USA). The RNAs extracted 
from the epidermis of 6 samples of each donor were diluted to the 
same concentration, and a SuperScript® VILO cDNA Synthesis 
Kit (Life Technologies) was used for reverse transcription into 
cDNA. Afterwards the cDNA was diluted to a concentration of 
1 ng/μL, and 5 ng (5 ng/μL to 20 ng for CXCL9, GM-CSF, IFN-γ, 
IL-6, chemerin) were used for quantitative PCR using SYBR® 
Green PCR Master Mix (Life Technologies, Thermo Scientific, 
USA) and QuantiTect Primer Assays (Qiagen GmbH, Germany) 
for 17 genes (IL-1α, IL-1β, TNF-α, CCL22, CXCL9, IL-8, IL-16, 
chemerin, CX3CL1, IP-10, GM-CSF, TGF-β, CCR7, IL-6, IL-1RA, 
CCL2, and IFN-β) tested.
Analysis
Semiquantitative quantification of RNA sequences was done 
by comparing ΔCT values, i.e., the gene-specific CT value was nor-
malized to the mean CT value of the housekeeping genes GADPH 
and β-actin for each sample. A normalization sample was used on 
every plate to account for interplate variability. For the statistical 
analysis, 1-tailed paired Wilcoxon tests were performed using 
Prism 5.0. Significance was recognized for samples where the dif-
ference between treatments was larger than the standard deviation 
of the normalization samples.
Results
Changes on skin barrier function can be measured us-
ing transepidermal water loss (TEWL), which increases 
as a function of tape strip number [21]. Although limited 
by high interindividual variations, TEWL is a valuable 
tool for the investigation of skin barrier turnover in re-
sponse to disruption methods. The degree of barrier dis-
ruption is influenced by the character of the tape and the 
method of application [22]. A marked increase in TEWL 
values was observed for approximately 5 min after CSSS 
and adhesive tape procedures in vivo (Fig. 1a). Compared 
to tape stripping, a return to baseline was slightly delayed 
in CSSS-treated areas. Stratum corneum hydration slight-
ly increased over time after both interventions (Fig. 1b). 
The skin surface pH decreased after CSSS (Fig. 1c), which 
is in accordance with the larger amount of stratum cor-
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No changes in skin elasticity were observed (Fig. 1d). Lev-
els of IL-1α, IL-6, and IL-8 collected by Sebutapes were 
determined before (baseline) and after (directly after, af-
ter 2 h, after 4 h, after 24 h, and after 48 h) both treatments 
in vivo. The amount of interleukin per Sebutape was nor-
malized to the amount of total soluble protein in the sam-
ple. A slight increase in IL-1α, a constitutively produced 
mediator, and a decrease in IL-1RA (receptor antagonist) 
(Fig. 2a and b, respectively) were observed. This effect was 
more pronounced after single tape stripping, probably 
because the preformed reservoir of IL-1α in the upper 
stratum corneum compartment was removed by CSSS. 
No new induction of IL-6 and IL-8, 2 inflammatory mark-
ers known to be produced in response to stress stimuli 
and marked skin barrier disruption, was observed in vivo 
(data not shown).
Volunteers indicated in the questionnaires that they 
would readily choose CSSS-based transcutaneous vacci-
nation as the vaccination method if available (11/12 
strongly agree), that they would prefer it over intramus-
cular injections given that the effects were equal (10/12 
strongly agree) and that they would consider CSSS-based 
vaccinations if that would allow to get protected against 
diseases for which no intramuscular vaccination exists 
(11/12 strongly agree). Pain assessment by visual ana-
logue scale revealed that pain perceived after intramuscu-
lar injection was rated markedly higher than CSSS and 
regular adhesive tape stripping (see online suppl. Fig. 2). 
No changes in interleukins measured in blood after 1 
single CSSS were observed. For IL-12p70 and TNF-α, re-
sults were negative. Results for IL-10, IL-6, IL-1β, and 






















2 h 4 h 24 h 48 h

































Fig. 1. Skin physiology measurements after CSSS compared to a 
single adhesive tape stripping procedure in vivo. An increase in 
TEWL was observed for both CSSS and tape directly after the pro-
cedure (a), with a quick recovery after 5 min. A small recovery 
delay was observed for the CSSS test areas. Stratum corneum hy-
dration (SCH) equally increased for both procedures (b), whereas 
pH strongly decreased after CSSS (c). No changes in skin elasticity 
(d) were observed. n = 12. Mean values are depicted, error bars 
represent standard deviation. “Base” stands for baseline and rep-
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We further investigated skin physiology in ex vivo skin 
samples at different time points (Fig. 4a). No significant 
differences were observed in TEWL before and after 24 h 
barrier disruption, similar to the in vivo result after 24 h. 
A significant increase in stratum corneum hydration was 
observed in CSSS-treated skin 24 h after disruption. Sim-
ilar to in vivo measurements a lower skin surface pH was 
noticeable after 24 h in untreated as well as in disrupted 
skin, reaching a level of significance in CSSS. Similar to 
our in vivo results, levels of IL-1α, IL-1β, and IL-1RA 
were analysed from Sebutapes 24 h after the disruption 
procedures in ex vivo skin and normalized to overall pro-
tein content (Fig. 4b). For the ex vivo samples the levels 
of IL-1β and IL-1RA were lower than the detection mini-
mum of the used kits. For IL-1α, similar to our in vivo 
measurements, the detected amount was highest after 
single tape stripping. There was no noticeable difference 
between CSSS-treated and non-disrupted skin.
For an additional analysis of the epidermal cytokine 
and chemokine milieu, qRT-PCR for a wide range of in-
flammatory mediators was performed on RNA extracts 
from ex vivo human skin samples. A preliminary selec-
tion of molecules of interest was performed according to 
results from a chemokine protein array (data not pub-
lished). Immunologically relevant molecules were select-
ed and in total 17 different genes were tested: IL-1α, 
IL-1β, TNF-α, CCL22, CXCL9, IL-8, IL-16, chemerin, 
CX3CL1, IP-10, GM-CSF, TGF-β, CCR7, IL-6, IL-1RA, 
CCL2, and IFN-β. Figure 5 shows a selection of molecules 
we investigated in our experiments. ΔCT values were 
compared between CSSS-treated and non-treated skin. 
While IL-1α and IL-1β did not show major differences in 
gene expressions, IL-1RA indicated a lower gene expres-
sion after CSSS. This is in agreement with the literature 
since an increased expression would be expected at an 
earlier time point and an increased IL-1/IL-1RA ratio as 
an indicator for inflammation [23–26]. A significantly in-
creased expression was observed for IP-10 (16 h) and 
TGF-β (4 h) compared to untreated skin. Similarly, in-
creased IL-8 and GM-CSF expression levels were found 
after 4 and 16 h of the CSSS procedure (Fig. 5). An in-
crease at time point 4 h and a subsequent decrease at time 
point 24 h were observed for IL-6 after CSSS.
Discussion
In vivo and ex vivo skin physiology measurements are 
comparable with each other. Mean TEWL baseline val-
ues are higher in vivo than ex vivo. Stratum corneum 
hydration showed a slight increase for both CSSS and 
tape stripping in vivo. In the ex vivo experiments this re-
sult is statistically significant after CSSS probably as a re-
sult of controlled temperature and humidity during the 
Base Directly
after

















































Fig. 2. a IL-1α content (normalized by total protein content) over 
time before and after cyanoacrylate skin surface stripping (CSSS) 
or single adhesive tape stripping (TS) in vivo. b IL-1RA content 
over time. n = 10. Mean values are depicted, error bars represent 
standard deviation. In black, results for CSSS and in grey, results 
for tape stripping are shown. “Base” stands for baseline and repre-
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incubation. pH values do not significantly change in vivo 
or ex vivo.
Despite CSSS being the more vigorous procedure, IL-
1α levels were higher after single adhesive tape stripping 
both in vivo and ex vivo (Fig. 2, 4). This is in accordance 
with the storage function of stratum corneum for pre-
formed IL-1α especially in superficial compartments. The 
origin of this cytokine was already reported to derive 
from an intracellular pool of damaged corneocytes and 
membrane-bound IL-1α [27]. This reservoir is substan-
tially reduced by CSSS compared to adhesive tape strip-
ping [23, 28]. 
We observed that the CSSS procedure was well toler-
ated and well accepted by all volunteers, and found no 
indication for marked inflammation within the first 48 h 
after the procedure. Skin barrier disruption after CSSS 
appeared to be only slightly higher compared to regular 
adhesive tape recovering fast after initial rise in TEWL. 
Clearly the study was designed as an explorative study in 
a small cohort (n = 12), and inclusion of more individu-
als may provide more substantial data. As for topical ap-
plications and transcutaneous drug delivery [10, 29], 
however, there seems to be an optimal time window for 
application directly after removal of the tape, i.e., both 
steps should be performed shortly after each other [10, 
29]. Late-stage (after 7 days and after 14 days) in vivo 
measurement of interleukin in blood after a single CSSS 
did not show significant changes. Those results were be-
low the threshold of positivity of the assay provided by 
the manufacturer. They demonstrate that CSSS per se 
does not cause measurable systemic inflammatory re-
sponses. Increases in IL-8 observed in transcutaneous 
vaccinated individuals were most likely the result of the 
combined use of CSSS and the topically applied vaccine 
[30]. In accordance with our in vivo data, our ex vivo re-
sults showed only minor changes in skin physiology 
measurements. Our findings are in line with safety and 
acceptability of ongoing clinical trials where local side ef-
fects of the procedure mostly resulted in transient ery-
thema.
Despite finding small differences in interleukin secre-
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Fig. 3. Interleukin measured in blood after 1 single CSSS (16 cm2). a Results for IL-10. b For IL-6. c For IL-1β. 
d For IL-8. Each spot represents a single subject (n = 5). Mean values are shown as a black line. Results are below 
the threshold of positivity of the assay; thus, CSSS does not induce prolonged alteration of interleukins in blood. 
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we know from previous studies that CSSS promotes acti-
vation of Langerhans cells (LCs) and cellular uptake [10]. 
Thus qRT-PCR allowed for additional analysis of the epi-
dermal cytokine and chemokine milieu in ex vivo sam-
ples. Although no changes were observed in the IL-1α, 
IL-1β and IL-1RA levels after CSSS either in skin surface 
analysis or in qRT-PCR, an increase of expression would 
be expected at an earlier time point [16, 23–25, 28]. This 
is also valid for IL-6 expression, a cytokine that plays a 
role in repair mechanisms and dendritic cell activation, 
and with highest protein levels generally detected be-
tween 2 and 7 h after barrier disruption, supported by our 
ex vivo results of higher expression 4 h after CSSS treat-
ment [15, 16, 23, 24, 31]. For IL-8, an indicator for sever-
ity of inflammation and attractant of neutrophils, our 
qRT-PCR results indicate a barrier reconstitution after 24 
h, which is coherent with our findings in skin physiology 
measurements for ex vivo probes [32, 33]. IL-8 is a che-
moattractant for neutrophils that also play a role in link-
ing neutrophils to the adaptive immunity [34]. An in-
crease is normally seen shortly after barrier perturbation 
as a sign of inflammation [15, 16, 35]. Interestingly, our 
early trials using CSSS for transcutaneous immunization 
also pointed towards systemic cytokine increase after in-
fluenza transcutaneous vaccination, e.g., IL-8 was elevat-
ed in transcutaneous vaccinated individuals [19]. An in-
crease in expression of GM-CSF, a pro-inflammatory cy-
tokine that enhances neutrophil and monocyte function, 
was observed indicating a role in early immune response 
[23, 24, 34, 35]. The ex vivo qRT-PCR measurements 
showed a change in gene expression for IP-10 and TGF-β, 
both modulators that contribute to the induction of Lang-
erhans cells and dendritic cell maturation as well as the 
positioning of CXCR3-positive T cells in the skin [16, 23, 
24, 36]. IP-10 together with IFN has already been de-
scribed as an important cytokine induced by barrier dis-
ruption methods like tape stripping [37, 38]. A 2-phased 
reaction of skin to barrier disruption has been described 
[39]. Some authors found a Th2- and eosinophil-focused 






































































Fig. 4. Skin physiology and cytokine measurements after 1 CSSS 
compared to a single tape stripping and untreated skin in ex vivo 
human skin. a TEWL measurements at different time points show 
no major differences between treatment methods. A significant 
decrease in pH at 24 h is observed after CSSS compared to non-
disrupted skin. SCH, stratum corneum hydration (capacitance). 
b IL-1α expression on the skin surface 24 h after treatment. A sig-
nificant increase in the amount of IL-1α on tape-stripped skin 
compared to non-disrupted skin is observed. No noticeable chang-
es in IL-1α expression after CSSS could be detected. Mean values 
and standard deviations are depicted. *p < 0.05. “Base” stands for 


























   
   
   
   
   






















Skin Pharmacol Physiol 2018;31:115–124
DOI: 10.1159/000484443
122
ters of anti-ovalbumin after application of a correspon-
dent vaccine when applied on tape-stripped skin [38, 40, 
41]. In this context different vaccine formulations might 
be worth comparing since other findings suggest higher 
antigen amount distribution to the hair follicle when the 
compound is encapsulated in nanoparticles [42]. We 
therefore conclude that while CSSS does not provoke 
massive barrier disruption it still presents an immuno-
logical stimulus. This information in combination with 
our other experimental ex vivo studies, where an in-
creased follicular penetration was detected accompanied 
by the creation of a particle reservoir [20], shows the po-
tential this method bears for transcutaneous vaccination 
and delivery strategies inducing only slight inflamma-
tion.
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Fig. 5. ΔCT values of a selection of molecules analysed by qRT-PCR in epidermal cell suspensions not treated or 
after CSSS at 3 different time points (4, 16, and 24 h) are shown. A normalization sample was used on every plate 
to account for interpolate variability. For the statistical analysis, 1-tailed paired Wilcoxon tests were performed. 
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The hair follicle is filled with sebum and scaled stratum 
corneum [2], and CSSS arises as a method that is able to 
open the hair follicle and prepare it for drug delivery. The 
removed protein material might be additionally quanti-
fied and analysed for inflammatory markers [6]. Thus, 
this mild barrier disruption method has the potential to 
become a simple, well-accepted diagnostic and penetra-
tion enhancement tool for dermatological research.
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